3 results
Approved WMOPending
Assess the efficacy and safety of eculizumab in pediatric patients with aHUS to control TMA as characterized by thrombocytopenia, hemolysis and renal impairment.
Approved WMOWill not start
Assess the efficacy of eculizumab in adult patients with aHUS to control TMA as characterized by thrombocytopenia, hemolysis and renal impairment.
Approved WMOPending
The aims of the study are (1) to establish the feasibility, safety, and potential efficacy of NcAcc DBS in patients with a chronic, treatment refractory heroin and/or cocaine addiction; (2) to explore functional effects of NcAcc DBS in terms of…